FDA approved first cell Based gene therapy to treat adult and pediatric patients with Beta-thalassemia
On Aug. 17, 2022, the U.S. Food and Drug Administration announced it had approved Zynteglo (betibeglogene autotemcel), the…
On Aug. 17, 2022, the U.S. Food and Drug Administration announced it had approved Zynteglo (betibeglogene autotemcel), the…
On Aug. 9, 1993, Francisco Mojica published “Transcription at different salinities of Haloferax mediterranei sequences adjacent to partially…